Quantcast

Obesity Crisis in Gynecologic Cancer

March 26, 2014

SAN DIEGO, March 26, 2014 /PRNewswire/ –

Latest special issue of journal Gynecologic Oncology addresses the impact of
obesity on gynecologic cancer patients, oncologists and cancer care delivery systems

The journal Gynecologic Oncology, the official journal of the Society of Gynecologic
Oncology, is pleased to announce the launch of a special issue
[http://www.sciencedirect.com/science/journal/00908258/133 ] on gynecologic cancer
prevention, treatment and survivorship in obese women. Working on the special issue, Guest
Editors Dr Susan C. Modesitt (University of Virginia School of Medicine) and Dr Joan
Walker (University of Oklahoma Health Sciences Center) brought together researchers
studying the influence of obesity on all components of gynecologic cancer care.

“The overweight and obesity epidemic affects clinical practice,” said Dr Modesitt.
“Previous data published shows that 72% of women in the US now have a BMI of greater than
or equal to 25 kg/m2. We still do not truly understand which facet of obesity is
carcinogenic and why only subsets of obese individuals develop cancer.”

As the proportion of the population which is overweight increases, patients no longer
perceive obesity to be either abnormal or a disease state. This makes it exceedingly
difficult to convince patients of the need for behavioral change and has given rise to
many of the research topics in the special issue, such as public health policy, cancer
prevention, all-cause mortality, treatment strategies, translational research, and
survivorship. Also published in the issue are reviews on the impact of obesity on
traditional cancer treatment modalities like surgery and chemotherapy.

“As a nation, the United States needs to be concerned about the responsibilities of
the medical system to manage morbidly obese women. We hope that this special issue
stimulates discussion and further research to find the data which are necessary to improve
our prevention, symptom management, supportive care, survivorship and cancer care delivery
program,” said Dr Walker.

The special issue is “Gynecologic Cancer Prevention, Treatment and Survivorship in
Obese Women”, Volume 133, Issue 1 (April 2014) of Gynecologic Oncology published by
Elsevier. The special issue is now available online on ScienceDirect
[http://www.sciencedirect.com/science/journal/00908258/133 ].

About Gynecologic Oncology

Gynecologic Oncology [http://www.gynecologiconcology-online.net ], an international
journal, is devoted to the publication of clinical and investigative articles that concern
tumors of the female reproductive tract. Investigations relating to the etiology,
diagnosis, and treatment of female cancers, as well as research from any of the
disciplines related to this field of interest, are considered for publication. Gynecologic
Oncology has an Impact Factor of 3.929, ranking it in the top 10% of journals in the
Obstetrics and Gynecologic category of the Journal Citation Reports and in the top 30% in
the Oncology category.

About the Society of Gynecologic Oncology

The Society of Gynecologic Oncology [http://www.sgo.org ] is the premier medical
specialty society for health care professionals trained in the comprehensive management of
gynecologic cancers. As a 501(c)(6) organization, the SGO contributes to the advancement
of women’s cancer care by encouraging research, providing education, raising standards of
practice, advocating for patients and members and collaborating with other domestic and
international organizations.

SGO has more than 1,800 members representing the entire gynecologic oncology team in
the United States and abroad. Members include primarily gynecologic oncologists, as well
as medical oncologists, pathologists, radiation oncologists, hematologists, surgical
oncologists, obstetrician/gynecologists, nurses, physician assistants, social workers,
fellows-in-training, residents and other allied health care professionals interested in
the treatment and care of women’s cancer. SGO members provide multidisciplinary cancer
treatment including chemotherapy, radiation therapy, surgery and supportive care. They
practice in a variety of settings, including academic institutions and hospitals, major
regional cancer centers and private practice.

It is the mission of the SGO to promote the highest quality of comprehensive clinical
care through education and research in the prevention and treatment of gynecologic
cancers.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the
performance of science, health, and technology professionals, empowering them to make
better decisions, deliver better care, and sometimes make groundbreaking discoveries that
advance the boundaries of knowledge and human progress. Elsevier provides web-based,
digital solutions – among them ScienceDirect [http://www.sciencedirect.com ], Scopus
[http://www.scopus.com ], Elsevier Research Intelligence
[http://www.elsevier.com/online-tools/research-intelligence ] and ClinicalKey
[https://www.clinicalkey.com ] – and publishes nearly 2,200 journals, including The Lancet
[http://www.thelancet.com ] and Cell [http://www.cell.com ], and over 25,000 book titles,
including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading provider of professional information solutions in the Science, Medical,
Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed
Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange),
RUK and ENL (New York Stock Exchange).

        Media contact
        Sarah Jenkins
        Elsevier
        +44(0)1865-843243
        sl.jenkins@elsevier.com

SOURCE Elsevier


Source: PR Newswire



comments powered by Disqus